Alek Safarian

Alek has a 35 year background in drug development, spanning Pharma, CRO and VC sectors. Trained as a pharmacist, Alek graduated with a MBA from the University of Sydney and has been awarded Doctor of Medicine and Health (honoris causa) by his alma mater for contributions to the field. Now based in London, Alek is the General Partner of ALSA Ventures, a life science venture investor focused on novel therapeutics.